As of April 19, 2025, Rafael Holdings (RFL) has a market cap of $53.836 million USD. According to our data, Rafael Holdings is ranked No.8026 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $53.84 M |
36.19%
|
Dec 31, 2024 | $39.53 M |
-9.84%
|
Dec 29, 2023 | $43.84 M |
-2.14%
|
Dec 30, 2022 | $44.80 M |
-63.33%
|
Dec 31, 2021 | $0.12 B |
-78.13%
|
Dec 31, 2020 | $0.56 B |
30.72%
|
Dec 31, 2019 | $0.43 B |
124.97%
|
Dec 31, 2018 | $0.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Fortress Biotech
FBIO
|
$45.19 M |
-0.000 M
|
![]() USA
|
![]() Verastem Oncology
VSTM
|
$0.30 B |
-0.000 M
|
![]() USA
|
![]() Karyopharm Therapeutics
KPTI
|
$42.42 M |
-0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
![]() TG Therapeutics
TGTX
|
$6.02 B |
-0.000 M
|
![]() USA
|
![]() Syndax Pharmaceuticals
SNDX
|
$0.99 B |
0.000 M
|
![]() USA
|
![]() MacroGenics
MGNX
|
$79.49 M |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
![]() Canada
|
Market Cap | = | RFL Stock Price | * | RFL Shares Outstanding |
= | $1.68 | * | 31.26 M | |
= | $53.84 M |